CBS 2019
CBSMD教育中心
HOME
CBS 2019
At CBS
General Information
Association and Affiliations
Organized by
Nanjing Heart Center
Asian Bifurcation Club (ABC)
Nanjing First Hospital, Nanjing Medical University
Co-organized by
Chinese Society of Cardiology (CSC)
Capacity Building and Continuing Education Center,National Health and Family Planning Commission (CBCEC)
American Society for Cardiovascular Angiography and Interventions (SCAI)
Asian Heart Society (AHS)
Contact Us
Registration Administration of Domestic Representatives
Hongjuan Peng :
+86-13913895477
Haimei Xu +86-13914736846
cbsnj@cbsmd.cn
Registration Administration of Overseas Representatives
Ling Lin : +86 (25) 52271398
+86-13951884596
cbs@cbsmd.cn
Management of Challenging Cases
Yingying Zhao :+86-13815408517
sub@cbsmd.cn
Address
CBS2019 Congress Secretariat, Nanjing First Hospital, Building No.9 68# Changle Road, Nanjing, China
210006
FACULTY
FACULTY
General Chairman
Congress Chairman
Education Center
Education Center
• Online Education (For more customized user interface with self-defined collection of research papers and education resources.)
• CBS Education Resource
• CBSMD Scientific Library
SCIENTIFIC LIBRARY
SCIENTIFIC LIBRARY
Research Paper
> Acute Coronary Syndrom
> ASCVD Prevention
> Bifurcation Stenting
> Cardio-Oncology
> Congestive Heart Failure
> DAPT Duration
> Drug Coated Balloon
> Fractional Flow Reserve
> IVUS Guidance
> Optical Coherence Tomography
> Pulmonary Hypertension
> Rotational Atherectomy
> Shear Stress
> Stenting Left Main
> Transcatheter Aortic Valve Replacement
> Percutaneous LAA Occlusion
> Mitral/Tricuspid Valvular Disease
> Other Relevant Articles
Recommended Paper
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic
ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)
心脏肿瘤科
JOURNAL： Article Link
作者：张航等 译者：邓云飞
摘要
目的：该研究旨在评价PADN（肺动脉去神经术）对PAH（肺动脉高压）患者长期生存率的影响。
方法和结果：本研究纳入2012年3月至2018年3月期间120名接受PADN治疗并完成随访的PAH患者。根据术前WHO心功能分级将PADN-PAH患者分为FC 1-2（心功能1-2级；n=46）和FC 3-4（心功能3-4级；n=74）两组。主要终点事件定义为截止到2021年3月的非肺移植相关死亡，次要终点事件为6MWD（6分钟步行距离）的改善。在中位期为4.8年的随访期内， 23名（19.2%）患者的事件可归类于全因死亡事件，FC 3-4组（25.7%）显著高于FC 1-2组（8.7%）（p=0.034）。FC 1-2组患者1年死亡率（2.2% vs 12.2%，p=0.087）与3年死亡率（6.5% vs 17.6%，p=0.102）均低于FC 3-4组患者。PADN术后，FC 3-4组患者的6MWD的净改善（+60.5m）较FC 1-2患者（+29m）更显著（p=0.037）。
结论：PADN术可以提升PAH患者（尤其是FC 3-4组）的长期生存率。该研究是注册研究PADN-1的延续。PADN-1研究注册网址：http://www.chictr.trc.com.cn. 唯一标识码: chiCTR-ONC-12002085.
总结：
1. PADN术可以显著降低PAH患者的长期死亡率；
2. PADN术对基线FC 3-4组PAH患者的生活质量的改善程度优于FC 1-2组。
中 文
CBS 2019
CBS 2019 FACULTY
Education Resource
CBSMD Scientific Library
